Mesco Pharmaceuticals informs about change in directorate

22 Jun 2019 Evaluate

Mesco Pharmaceuticals has informed that Board of Directors had approved the appointment of Hawa Singh Chahar as an Additional Director (Non-Executive Independent Director) on the Board of the Company to hold office with immediate effect subject to the approval of shareholders of the company in the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.


Mesco Pharma Share Price

4.54 0.00 (0.00%)
10-Jan-2022 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×